Biopharma and life sciences companies face unique challenges when valuing their clinical trial materials in compliance with U.S. customs valuation regulations. These valuation decisions can have significant impacts on the amount of duties and tariffs owed, particularly in today’s volatile trade policy environment. This webinar will provide an overview of basic U.S. customs law valuation principles and highlights specific areas relevant for clinical trials.
About The Webinar
Key Topics
- The World Customs Organization’s Customs Valuation Agreement
- Basic concepts of customs valuation
- Valuation tools and resources
- Valuation Methods
- Clinical Trial Valuation Examples
- Best Practices for Clinical Trial Valuation and Recordkeeping
Speaker 

Andrea K. Jeglum Associate
Andrea K. Jeglum Associate
ANDREA K. JEGLUM is an associate with Sandler, Travis & Rosenberg, P.A., located in the Boston area. She concentrates her practice on customs compliance matters including tariff classification, country of origin, valuation, trade agreements, foreign-trade zones, and duty reduction programs. She also helps clients meet U.S. requirements concerning trade in biopharma, agro-chemicals, and animal products, including endangered species, as well as export filings and enforcement measures.
Other Webinars from Andrea K. Jeglum
-
On Demand
Learn MoreUnderstanding U.S. Customs Valuation in the Biopharma and Life Sciences Industry
Customs & Import Compliance -
On Demand
Learn MoreUsing the Prototype Provision for Duty Savings
Tariff Classification, Tariff Engineering & Chapter 98 Provisions -
On Demand
Learn MoreBuying DDP: Protection Against Customs Compliance Liability?
Customs & Import Compliance
Contact Us